Real Clinical Practice Data of Monthly Dupilumab Therapy in Adult Patients With Moderate-to-Severe Atopic Dermatitis: Clinical Efficacy and Predictive Markers for a Favorable Clinical Response.

Lee, Youngsoo; Kim, Myoung-Eun; Nahm, Dong-Ho

Lee, Youngsoo; Kim, Myoung-Eun; Nahm, Dong-Ho.

Afiliação

Lee Y; Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea.
Kim ME; Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea.
Nahm DH; Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea. dhnahm@gmail.com.

Allergy Asthma Immunol Res ; 13(5): 733-745, 2021 Sep.

Article em En | MEDLINE | ID: mdl-34486258

Palavras-chave

Atopic dermatitis; IL-4; clinical efficacy; dupilumab; eosinophil; marker

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Allergy Asthma Immunol Res Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google